Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatorenal Syndrome Type I”

12 trials

Showing 12 of 12 results

Not applicableTemporarily pausedNCT04898010
What this trial is testing

The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I

Who this might be right for
Acute Kidney InjuryHepatorenal Syndrome
Lenar Yessayan 10
Large-scale testing (Phase 3)UnknownNCT00742690
What this trial is testing

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

Who this might be right for
CirrhosisType 1 Hepatorenal Syndrome
University of Padova 70
Large-scale testing (Phase 3)Study completedNCT00089570
What this trial is testing

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 112
Post-approval studies (Phase 4)Study completedNCT03455322
What this trial is testing

Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

Who this might be right for
Renal Impairment in Hepatorenal Syndrome
National Hepatology & Tropical Medicine Research Institute 60
Large-scale testing (Phase 3)Study completedNCT01143246
What this trial is testing

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 196
Large-scale testing (Phase 3)Study completedNCT02770716
What this trial is testing

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 300
Not applicableEnded earlyNCT02123576
What this trial is testing

Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline

Who this might be right for
Hepatorenal Syndrome
Patrick Northup, MD 12
Early research (Phase 1)Ended earlyNCT01906307
What this trial is testing

LJPC-501 in Patients With Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome Type I and Type II
La Jolla Pharmaceutical Company 6
Testing effectiveness (Phase 2)Study completedNCT01373606
What this trial is testing

Terlipressin in Patients With Hepatorenal Syndrome Type 1

Who this might be right for
Hepatorenal Syndrome Type 1
Ferring Pharmaceuticals 8
Large-scale testing (Phase 3)Ended earlyNCT00742339
What this trial is testing

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Who this might be right for
CirrhosisHepatorenal Syndrome
University of Padova 49
Post-approval studies (Phase 4)UnknownNCT01530711
What this trial is testing

Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

Who this might be right for
CirrhosisHepatorenal Syndrome Type I
Pere Gines 40
Large-scale testing (Phase 3)Study completedNCT03822091
What this trial is testing

Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1

Who this might be right for
Type 1 HEPATO RENAL SYNDROME(HRS)
Post Graduate Institute of Medical Education and Research, Chandigarh 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation